Cargando…

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is characterized by an atherogenic dyslipidaemia and an increased cardiovascular risk. Remnant lipoprotein cholesterol (RLP-C) is emerging as a novel cardiovascular risk factor, but its predictive value in patients with NAFLD is unknown. We investigated fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastori, Daniele, Baratta, Francesco, Novo, Marta, Cocomello, Nicholas, Violi, Francesco, Angelico, Francesco, Del Ben, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262373/ https://www.ncbi.nlm.nih.gov/pubmed/30360566 http://dx.doi.org/10.3390/jcm7110378

Ejemplares similares

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
por: Ferro, Domenico, et al.
Publicado: (2020)

Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide Are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2020)

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
por: Baratta, Francesco, et al.
Publicado: (2015)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2015)

Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
por: Coronati, Mattia, et al.
Publicado: (2022)

Sex-Related Differences in the Association between Metabolic Syndrome and Gallstone Disease
por: Baratta, Francesco, et al.
Publicado: (2021)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study
por: Baratta, Francesco, et al.
Publicado: (2021)

Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress
por: Carpino, Guido, et al.
Publicado: (2017)

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis
por: Pastori, Daniele, et al.
Publicado: (2021)

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Di Costanzo, Alessia, et al.
Publicado: (2020)

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
por: Del Ben, Maria, et al.
Publicado: (2014)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
por: Chin, Justin, et al.
Publicado: (2020)

Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
por: Pastori, Daniele, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and the Kidney: A Review
por: Umbro, Ilaria, et al.
Publicado: (2021)

Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease
por: Zou, Yang, et al.
Publicado: (2022)

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
por: Di Costanzo, Alessia, et al.
Publicado: (2018)

Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease
por: Ferri, Flaminia, et al.
Publicado: (2020)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population
por: Cheang, Iokfai, et al.
Publicado: (2022)

Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
por: Cammisotto, Vittoria, et al.
Publicado: (2021)

Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients
por: Baratta, Francesco, et al.
Publicado: (2023)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Moderate Weight Loss Decreases Oxidative Stress and Increases Antioxidant Status in Patients with Metabolic Syndrome
por: Del Ben, Maria, et al.
Publicado: (2012)

Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations
por: Lütjohann, Dieter, et al.
Publicado: (2023)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2023)

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease
por: Cheng, Yiping, et al.
Publicado: (2023)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
por: Del Ben, Maria, et al.
Publicado: (2018)

A review of picotamide in the reduction of cardiovascular events in diabetic patients
por: Celestini, Andrea, et al.
Publicado: (2007)

The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study
por: Pignatelli, Pasquale, et al.
Publicado: (2022)

Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment
por: Del Ben, Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o8tghstd98kefh8q9hqio2dta5